Skip to main content
NIH funding notice RFA-AI-20-029

Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional)

Closed on October 9, 2020.

Posted
April 15, 2020
Close date
October 9, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $16,025,773 in first-year total cost, median $2,295,742.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 JTS-I (M1)]9

Most frequent institutions

  1. DUKE UNIVERSITY2
  2. BOSTON CHILDREN'S HOSPITAL1
  3. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  4. MASSACHUSETTS GENERAL HOSPITAL1
  5. NORTHWESTERN UNIVERSITY AT CHICAGO1
Competing awards under RFA-AI-20-029 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Lung Transplant Clinical Trial Network (LT-CTN)1U01AI163099-01BELPERIO, JOHN APALMER, SCOTT MSWEET, STUART CDUKE UNIVERSITY, NC$2,981,212ZAI1
2021Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation1U01AI163087-01BHOJ, VIJAYGARFALL, ALFRED L.JUNE, CARL H.MARKMANN, JAMES FRANCISMILONE, MICHAEL C.NAJI, ALIUNIVERSITY OF PENNSYLVANIA, PA$2,975,228ZAI1
2021Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab1U01AI163086-01HACHEM, RAMSEYKREISEL, DANIELMADSEN, JOREN CMASSACHUSETTS GENERAL HOSPITAL, MA$2,710,272ZAI1
2021Advancing Transplantation Outcomes in Children1U01AI163072-01BRISCOE, DAVID M.BOSTON CHILDREN'S HOSPITAL, MA$2,341,354ZAI1
2021Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)1U01AI163090-01CHEN, YING QINGDIAMOND, DON JFISHER, CYNTHIA ELIMAYE, ABHIJIT PRAKASHUNIVERSITY OF WASHINGTON, WA$2,295,742ZAI1
2021Targeting the B Cell Response to Treat Antibody-Mediated Rejection1U01AI163065-01KNECHTLE, STUART JOHNSTONDUKE UNIVERSITY, NC$1,561,304ZAI1
2021Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression1U01AI163081-01LEVITSKY, JOSHNORTHWESTERN UNIVERSITY AT CHICAGO, IL$1,160,659ZAI1
2021CTOT: Biomarker guided CNI substitution in kidney transplantation2U01AI063594-18HEEGER, PETER SCOTTNICKERSON, PETER WICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$1ZAI1
2021Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE)2U01AI113362-08VINCENTI, FLAVIOUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$1ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-20-029: Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) | ScienceDex | ConductScience